GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
PHILADELPHIA, PA, March 15, 2005 GlaxoSmithKline (NYSE: GSK) today announced that its booster vaccine candidate, BoostrixTM [Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (Tdap)] received a unanimous favorable recommendation from the Vaccines and Related Biological Products Advisory Committee of the U.S. Food and Drug Administration (FDA). Currently, there...SAM on the favorable recommendation by FDA Advisory Committee for Boostrix
BLUE SPRINGS, MO March 15, 2005 The Society for Adolescent Medicine supports the unanimous favorable recommendation of the Vaccines and Related Biological Products Advisory Committee of the U.S. Food and Drug Administration (FDA) regarding the development of a vaccine to prevent the occurrence of pertussis in adolescents. We believe that the development of this vaccine will further the health...